VALLEY COTTAGE, New York, October 4, 2017 /PRNewswire/ -- The global molecular imaging market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand for advanced integrated molecular imaging devices such as PET-CT and PET-MR from hospitals and diagnostics imaging centres. "Molecular Imaging Market: Global Industry Analysis (2012 -2016) and Opportunity Assessment (2017 - 2027)," is the newly published report by Future Market Insights which focuses on the key strategies such as acquisitions, mergers, expansion and product launches adopted by the manufacturers and integrators in this market for technology transfer and to increase consumer base in different geographies. The global molecular imaging market is projected to register a CAGR of 7.5% in terms of value during the forecast period i.e. 2017-2027 and to be valued at US$ 6,445.8 Mn by 2027.

Global Market Research Report Overview on Molecular Imaging @ https://www.futuremarketinsights.com/reports/molecular-imaging-market

Global Molecular Imaging Market: Drivers
Following are some of the factors which are contributing in the growth of the global molecular imaging market throughout the forecasted period.

Advancements in the molecular imaging.
Favorable reimbursement for molecular imaging and treatment.
Increasing demand for molecular imaging and diagnosis.
Increasing incidences of ageing population's MRI diagnostics.
Expanding application of integrated PET-CT and PET-MR devices.
Favorable government policies for startup companies.
Increasing Strategic Collaborations among key players.
Increasing reliance of physicians and radiologists on the technology.
View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/molecular-imaging-market/toc

Global Molecular Imaging Market: Forecast by Modality Type

On the basis of modality type, the global molecular imaging market is segmented into- Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT),

Positron Emission Tomography-Magnetic Resonance (PET-MR), Single Photon Emission, Computed Tomography (SPECT), Magnetic Resonance Spectroscopy, Molecular Ultrasound Imaging Software. The SPECT segment of modality type accounted for 23.3%market share in 2016, which is expected to decrease to 22.7% by 2027end. This segment is expected to accounts for large revenue contributionto the global molecular imaging market as compared to other segmentsover the forecast period. On the other hand PET-CT molecular imaging segment is expected to witness a significant rise in revenue share over the forecast period, owing to increasing awareness about the advantages of PET-CT integrated devices compared to stand alone molecular imaging devices.

Molecular Imaging Homepage